B. Riley Lowers Aspen Aerogels (NYSE:ASPN) Price Target to $22.00

Aspen Aerogels (NYSE:ASPN) had its target price decreased by equities research analysts at B. Riley from $35.00 to $22.00 in a note issued to investors on Wednesday,Benzinga reports. The brokerage currently has a “buy” rating on the construction company’s stock. B. Riley’s target price points to a potential upside of 154.31% from the stock’s current price.

Other equities research analysts have also recently issued reports about the stock. Craig Hallum decreased their price objective on shares of Aspen Aerogels from $21.00 to $18.00 and set a “buy” rating for the company in a report on Friday, February 14th. StockNews.com raised shares of Aspen Aerogels to a “sell” rating in a report on Wednesday. Roth Mkm reduced their price objective on shares of Aspen Aerogels from $22.00 to $16.00 and set a “buy” rating on the stock in a research note on Friday, February 14th. Piper Sandler dropped their price objective on shares of Aspen Aerogels from $36.00 to $33.00 and set an “overweight” rating on the stock in a report on Tuesday, October 22nd. Finally, Barclays decreased their price objective on shares of Aspen Aerogels from $25.00 to $13.00 and set an “overweight” rating for the company in a research report on Wednesday. One research analyst has rated the stock with a sell rating, one has assigned a hold rating and nine have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $22.44.

Aspen Aerogels Stock Up 1.3 %

Shares of NYSE ASPN opened at $8.65 on Wednesday. Aspen Aerogels has a 1 year low of $8.25 and a 1 year high of $33.15. The firm has a market cap of $709.81 million, a price-to-earnings ratio of 54.14 and a beta of 2.14. The company has a debt-to-equity ratio of 0.27, a quick ratio of 2.48 and a current ratio of 2.93. The stock’s 50-day simple moving average is $12.06 and its 200-day simple moving average is $18.36.

Aspen Aerogels (NYSE:ASPN) last issued its quarterly earnings data on Wednesday, February 12th. The construction company reported $0.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.04 by $0.11. Aspen Aerogels had a return on equity of 7.49% and a net margin of 2.95%. As a group, equities analysts anticipate that Aspen Aerogels will post 0.46 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Aspen Aerogels

Institutional investors have recently added to or reduced their stakes in the stock. Lord Abbett & CO. LLC bought a new stake in shares of Aspen Aerogels during the third quarter worth $10,126,000. Oppenheimer & Co. Inc. boosted its position in Aspen Aerogels by 167.2% in the third quarter. Oppenheimer & Co. Inc. now owns 102,535 shares of the construction company’s stock valued at $2,839,000 after buying an additional 64,154 shares during the last quarter. Sanders Morris Harris LLC lifted its holdings in Aspen Aerogels by 337.5% in the fourth quarter. Sanders Morris Harris LLC now owns 35,000 shares of the construction company’s stock valued at $436,000 after acquiring an additional 27,000 shares during the period. Penserra Capital Management LLC acquired a new position in shares of Aspen Aerogels during the 3rd quarter worth approximately $1,342,000. Finally, Geode Capital Management LLC raised its stake in Aspen Aerogels by 5.7% in the 3rd quarter. Geode Capital Management LLC now owns 1,385,968 shares of the construction company’s stock valued at $38,385,000 after purchasing an additional 75,024 shares during the last quarter. 97.64% of the stock is owned by hedge funds and other institutional investors.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.